Merrion revenue surges by 186%

DUBLIN-based drug-making firm, Merrion Pharmaceuticals has reported a solid set of results for 2008; showing a marked reduction in net losses and a 186% surge in revenue to €1.34 million.

The company’s net loss was narrowed by as much 58% to just over €5m. In real monetary terms, this was down from a net loss — in 2007 — of €12.07m.

Merrion’s loss per share levels also fell over the course of the year, down from €1.60 to 30c. It also currently has no debt. The revenue figure of €1.34m was up from €469,000 in the previous year.